中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共8条，第1-8条

帮助

条数/页：排序方式：
	Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR-ABL-Positive Leukemia 期刊论文 OAI收割 CANCER RESEARCH, 2025, 卷号: 85, 期号: 1, 页码: 101-117 作者: Luo, Ziwei; Lin, Chencen; Yu, Chuwei; Yuan, Changxian; Wu, Wenyong \| 收藏 \| 浏览/下载：11/0 \| 提交时间：2025/02/28
	MiR-337-3p improves metabolic-associated fatty liver disease through regulation of metabolism 期刊论文 OAI收割 ISCIENCE, 2023, 卷号: 26, 期号: 11, 页码: 18 作者: Xu, Xiaoding; Yu, Chuwei; He, Hongxiu; Pan, Xiangyu; Hou, Aijun \| 收藏 \| 浏览/下载：41/0 \| 提交时间：2024/01/16
	MiR-552-3p Regulates Multiple Fibrotic and Inflammatory genes Concurrently in Hepatic Stellate Cells Improving NASH-associated Phenotypes 期刊论文 OAI收割 INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2023, 卷号: 19, 期号: 11, 页码: 3456-3471 作者: Ma, Ningning; Hou, Aijun; Pan, Xiangyu; Sun, Fuguang; Xu, Xiaoding \| 收藏 \| 浏览/下载：20/0 \| 提交时间：2023/10/17 MiR-552-3p NASH Fibrosis Inflammation Synergistic multi-target suppression
	CSAD Ameliorates Lipid Accumulation in High-Fat Diet-Fed Mice 期刊论文 OAI收割 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 卷号: 23, 期号: 24, 页码: 14 作者: Tan, Rongrong; Li, Jiayang; Liu, Lu; Wu, Qian; Fan, Lei \| 收藏 \| 浏览/下载：51/0 \| 提交时间：2023/04/10 NAFLD CSAD obesity liver damage fatty acid beta-oxidation mitochondrial damage
	MicroRNA-379-5p regulates free cholesterol accumulation and relieves diet induced-liver damage in db/db mice via STAT1/HMGCS1 axis 期刊论文 OAI收割 Molecular biomedicine, 2022, 卷号: 3, 期号: 1, 页码: 25 作者: Dong, Yunxia; Yu, Chuwei; Ma, Ningning; Xu, Xiaoding; Wu, Qian \| 收藏 \| 浏览/下载：42/0 \| 提交时间：2024/03/15 Cholesterol metabolism HMGCS1 MiR-379-5p Non-alcoholic fatty liver disease STAT1
	Advances of microRNAs in regulating mitochondrial function: new potential application in NAFLD treatment 期刊论文 OAI收割 MOLECULAR BIOLOGY REPORTS, 2022, 页码: 13 作者: Yu, Chuwei; Chen, Jing; Ren, Jin \| 收藏 \| 浏览/下载：26/0 \| 提交时间：2022/08/16 NAFLD Mitochondrion MiRNA Mitochondrial dysfunction Metabolic diseases
	MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice 期刊论文 OAI收割 METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 卷号: 119, 页码: 12 作者: Xu, Xiaoding; Dong, Yunxia; Ma, Ningning; Kong, Weiwen; Yu, Chuwei \| 收藏 \| 浏览/下载：40/0 \| 提交时间：2021/08/17 miR-337-3p PCSK9 LDL-C Hyperlipidemia Dual regulation
	New PCSK9 inhibitor miR-552-3p reduces LDL-C via enhancing LDLR in high fat diet-fed mice 期刊论文 OAI收割 PHARMACOLOGICAL RESEARCH, 2021, 卷号: 167, 页码: 13 作者: Ma, Ningning; Fan, Lei; Dong, Yunxia; Xu, Xiaoding; Yu, Chuwei \| 收藏 \| 浏览/下载：56/0 \| 提交时间：2021/08/17 PCSK9 Hyperlipidemia MiR-552-3p 3 '-UTR Promoter